The Journal of Clinical Trials aims to serve as a dynamic, interdisciplinary platform for disseminating high-quality research that enhances the design, execution, reporting, and translation of clinical investigations. We are committed to advancing medical knowledge and improving patient outcomes by publishing scientifically sound, ethically conducted, and clinically meaningful studies across the full spectrum of human health and disease.

✳️ Our Primary Aims:

• To support the global clinical research community by publishing rigorously peer-reviewed, ethically conducted, and transparent trials.
• To provide visibility to novel methodologies, emerging trial designs, and digital innovations that enhance trial efficiency and participant safety.
• To foster dialogue between academia, healthcare providers, regulatory agencies, industry stakeholders, and patient communities.

✳️ Scope of the Journal Includes (but is not limited to):

• Clinical Trial Phases I–IV
  Investigations covering drug, biologic, vaccine, and device development throughout their entire lifecycle.
• Trial Methodology & Protocols
  Innovations in trial design, endpoint selection, sample size calculation, randomization, blinding, and adaptive methodologies.
• Decentralized and Hybrid Trials
  Research on virtual trials, remote monitoring, digital tools, and telemedicine integration.
• Real-World Evidence (RWE) & Post-Marketing Studies
  Studies evaluating treatment outcomes in diverse, real-world populations.
• Patient-Centered Outcomes
  Research focused on quality of life, patient satisfaction, adherence, and shared decision-making.
• Bioethics, Consent, and Regulatory Science
  Analyses on informed consent models, trial ethics, data privacy, and international regulatory compliance.
• Innovative Therapies & Precision Medicine
  Trials involving gene therapies, biologics, personalized interventions, and targeted approaches.
• Interdisciplinary and Multicentre Trials
  Collaborations across institutions, regions, or disciplines that contribute to scalable and generalizable findings.

The journal also welcomes trial protocols, pilot studies, statistical analyses, meta-research, systematic reviews, brief reports, and regulatory perspectives relevant to clinical investigation.

By providing open access to cutting-edge research and expert insights, the Journal of Clinical Trials strives to accelerate medical discovery, improve trial transparency, and strengthen the bridge between clinical research and real-world impact.